Visualising molecular messengers in chronic lymphocytic leukaemia
- Researcher: Dr Massimo Degano
- Institution: Fondazione Centro San Raffaele, Milan, Italy
- Award Amount: £162,900 for 3 years from 1st February 2019
- Cancer Type: Blood Cancer, Leukaemia
Blocking the molecular signals transmitted into the cell from B-cell receptors is a promising therapeutic strategy for treating CLL patients, but the drugs that have designed to do this don’t work for every patient and can have unwanted side effects. Dr Massimo Degano, based at Fondazione Centro San Raffaele in Milan, is studying the varied molecular structures of B-cell receptors to understand why this is the case.
Using sophisticated chemical techniques, the team will work out the 3-dimensional structure of the different types of B-cell receptor, before using this information to identify drugs that can interact with the B-cell receptor and stop it working in CLL.
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.